Is BCRX stock a Buy, Sell, or Hold?

Based on our analysis, BCRX is currently a HOLD with moderate confidence. 📊 HOLD: BCRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BCRX stock?

Our analysis estimates the fair value range for BCRX to be between $6.74 and $7.63. The current price is $6.58.

What is the analyst price target for BCRX?

The average Wall Street analyst price target for BCRX is $21.78. This implies a potential upside of 231.0% from current levels.

BCRX Stock Analysis: Buy, Sell, or Hold?

BCRX - BioCryst Pharmaceuticals Inc

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

$6.58

-0.09 (-1.35%) ▼

5d: -3.09%

30d: -14.1%

90d: -9.99%

HOLD

MODERATE Confidence

Protect Your BCRX Gains

Last Updated: January 30, 2026

Earnings: Feb 23, 2026 20d

Smart Money Accumulation

BCRX is down 3.1% this week, but smart money is accumulating calls. Top strike: $8 2026-03-20 with 5,285 OI. Call ratio: 96% View Scanner →

Strength: 6.1/10

Get Alerted When BCRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BCRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: -20.8%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$5.72

Based on -8.4% avg growth

INTRINSIC VALUE TODAY

$3.55

Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.6x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BCRX is currently trading at $6.58, which is considered oversold relative to its 30-day fair value range of $6.74 to $7.63. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.7) compared to its historical average (21.6). Remarkably, the market is currently pricing in an annual earnings decline of 10.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, BCRX is in a downtrend. The price is currently testing key support at $6.42. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BCRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $21.78 (+231.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $6.74 - $7.63

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding BCRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 231.0% below Wall St target ($21.78)

Fair Price Analysis

30-Day Fair Range $6.74 - $7.63

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $6.42

Resistance Level $7.17

Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 15.67

Wall Street Target $21.78 (+231.0%)

Revenue Growth (YoY) 36.1%

Profit Margin -1.5%

Valuation Discount vs History -10.1% cheaper

PE vs Historical 15.7 vs 21.6 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -10.1% (market-implied from PE analysis)

1-Year Target $5.92 (-10%)

2-Year Target $5.33 (-19%)

3-Year Target $4.80 (-27%)

3-Yr Target (if PE normalizes) (PE: 16→22) $6.61 (+1%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 22.3, Growth: -20.8%) $6.83 (+4%)

Base: (SPY PE: 15.7, Growth: -20.8%) $4.80 (-27%)

Bear: (PE: 13.3, Growth: -20.8%) $4.08 (-38%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 15.7 to 21.6

Stabilization Target: $9.07 (+37.9%)

PE Expansion Potential: +37.9%

Last updated: February 02, 2026 3:02 AM ET
Data refreshes hourly during market hours. Next update: 4:02 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BCRX showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Theresa Heggie SELL 70000 shares 2025-08-13

View Insider Activity Scanner

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 25 analysts	$180	62 BUY
ZTS Zoetis Inc	STRONG BUY 19 analysts	$154	56 HOLD
LNTH Lantheus Holdings Inc	STRONG BUY 13 analysts	$83	57 HOLD
HCM HUTCHMED DRC	STRONG BUY 14 analysts	$21	57 HOLD
TEVA Teva Pharma Industries L…	STRONG BUY 11 analysts	$37	54 HOLD

NBIX Neurocrine Biosci…

62 BUY

ZTS Zoetis Inc

56 HOLD

LNTH Lantheus Holdings…

57 HOLD

HCM HUTCHMED DRC

57 HOLD

TEVA Teva Pharma Indus…

54 HOLD

Advanced BCRX Option Strategies

Professional options setups generated by AI based on today's BCRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BCRX

BCRX Technical Chart BCRX Price Prediction BCRX Earnings Date BCRX Investment Advisor BCRX Fair Price Analyzer BCRX Options Advisor BCRX Options Chain BCRX Options Analysis BCRX Competitors

Compare BCRX with Other Stocks

BCRX vs CCL
Winner: CCL

ALNT vs BCRX
Winner: ALNT

BCRX vs MRNA

BCRX vs TECH
Winner: TECH

BCRX vs CRDO

BCRX vs BNTX
Winner: Tie

Create New Comparison

Tradestie